CRP and Sepsis: A statistically significant increase in the concentrations of sepsis-associated aromatic microbial metabolites (p-HPhLA, Σ3AMM) and biomarkers (CRP, PSP) in non-survivors suggests that metabolic dysfunction should be assessed for its timely targeted correction in the future.